Literature DB >> 2934361

In-vitro susceptibility of mycobacteria to ciprofloxacin.

C H Collins, A H Uttley.   

Abstract

Two hundred and seventy-six strains of mycobacteria were tested for susceptibility to ciprofloxacin (Bay 0 9867), a 4-quinolone antimicrobial agent. Most strains of Mycobacterium tuberculosis, Myco. fortuitum, Myco. kansasii, Myco. marinum and Myco. xenopi were sensitive to minimum inhibitory concentrations (MICs) of 0.78-1.56 mg/l, equivalent to resistance ratios of 1 or 2. Most strains of Myco. avium-intracellulare and Myco. chelonei required MICs of 12.5 mg/l or more, giving resistance ratios of 8.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2934361     DOI: 10.1093/jac/16.5.575

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

Review 1.  New antituberculous drugs in development.

Authors:  Umesh G Lalloo; Anish Ambaram
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

Review 2.  Mycobacteria and the new quinolones.

Authors:  D C Leysen; A Haemers; S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

3.  MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.

Authors:  L B Heifets; P J Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

Review 4.  Infections caused by opportunist mycobacteria: a review.

Authors:  J M Grange; M D Yates
Journal:  J R Soc Med       Date:  1986-04       Impact factor: 5.344

Review 5.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

6.  Antimycobacterial activities of novel levofloxacin analogues.

Authors:  K Kawakami; K Namba; M Tanaka; N Matsuhashi; K Sato; M Takemura
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

Review 7.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 8.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

9.  Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.

Authors:  E A Gorzynski; S I Gutman; W Allen
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

10.  In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.

Authors:  J Texier-Maugein; M Mormède; J Fourche; C Bébéar
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.